$250.83
-18.17-6.75%
Last update: Nov 11, 4:20 AM
Moderna Inc
MRNANASDAQ
The average analyst price target for Moderna is $85.83, 66.3% below the current price. Of 18 analysts, 3 rate it Buy, 10 Hold and 5 Sell. Targets range from $18 to $305. The latest change came on Nov 9, 2026, when Goldman Sachs raised its price target on Moderna from $137 to $195 and kept a Neutral rating.
Price Target Range — 10 Quarters
Analyst Consensus — 18 Analysts
Rating Trend — Last 9 Months
